Evidence map›Paper›PMID 33760809›Full record

ArticlePLoS neglected tropical diseases2021

Distinct features of the Leishmania cap-binding protein LeishIF4E2 revealed by CRISPR-Cas9 mediated hemizygous deletion.

Nofar Baron, Nitin Tupperwar, Irit Dahan, Uzi Hadad, Geula Davidov, Raz Zarivach, Michal Shapira

Open access · goldAbstract read
In one paragraph

Article in PLoS neglected tropical diseases, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 11 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Finding Correlations Between mRNA and Protein Levels inFrontiers in cellular and infection microbiology · 2022
    Review
  5. Characterization of an Atypical eIF4E Ortholog inInternational journal of molecular sciences · 2021
    Article
  6. LeishIF4E-5 Is a Promastigote-Specific Cap-Binding Protein inInternational journal of molecular sciences · 2021
    Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 2 countries.

Nofar BaronDepartment of Life Sciences, Ben-Gurion University of the Negev, Beer Sheva, Israel.
Nitin TupperwarDepartment of Life Sciences, Ben-Gurion University of the Negev, Beer Sheva, Israel.
Irit DahanDepartment of Life Sciences, Ben-Gurion University of the Negev, Beer Sheva, Israel.
Uzi HadadIlse Katz Institute for Nanoscale Science and Technology, Ben-Gurion University of the Negev, Beer Sheva, Israel.
Geula DavidovDepartment of Life Sciences, Ben-Gurion University of the Negev, Beer Sheva, Israel.ORCID 0000-0001-5153-4940
Raz ZarivachDepartment of Life Sciences, Ben-Gurion University of the Negev, Beer Sheva, Israel.ORCID 0000-0001-6543-0296
Michal ShapiraDepartment of Life Sciences, Ben-Gurion University of the Negev, Beer Sheva, Israel.ORCID 0000-0002-6164-7874
Ben-Gurion University of the Negev · IL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Leishmania parasites cycle between sand-fly vectors and mammalian hosts adapting to alternating environments by stage-differentiation accompanied by changes in the proteome profiles. Translation regulation plays a central role in driving the differential program of gene expression since control of gene regulation in Leishmania is mostly post-transcriptional. The Leishmania genome encodes six eIF4E paralogs, some of which bind a dedicated eIF4G candidate, and each eIF4E is assumed to have specific functions with perhaps some overlaps. However, LeishIF4E2 does not bind any known eIF4G ortholog and was previously shown to comigrate with the polysomal fractions of sucrose gradients in contrast to the other initiation factors that usually comigrate with pre-initiation and initiation complexes. Here we deleted one of the two LeishIF4E2 gene copies using the CRISPR-Cas9 methodology. The deletion caused severe alterations in the morphology of the mutant cells that became round, small, and equipped with a very short flagellum that did not protrude from its pocket. Reduced expression of LeishIF4E2 had no global effect on translation and growth, unlike other LeishIF4Es; however, there was a change in the proteome profile of the LeishIF4E2(+/-) cells. Upregulated proteins were related mainly to general metabolic processes including enzymes involved in fatty acid metabolism, DNA repair and replication, signaling, and cellular motor activity. The downregulated proteins included flagellar rod and cytoskeletal proteins, as well as surface antigens involved in virulence. Moreover, the LeishIF4E2(+/-) cells were impaired in their ability to infect cultured macrophages. Overall, LeishIF4E2 does not behave like a general translation factor and its function remains elusive. Our results also suggest that the individual LeishIF4Es perform unique functions.

Indexed as

Adaptation, PhysiologicalAmino Acid SequenceAnimalsAntigens, SurfaceCells, CulturedCRISPR-Cas SystemsCytoskeletal ProteinsEukaryotic Initiation Factor-4EEukaryotic Initiation Factor-4GGene Expression RegulationHumansLeishmaniaMacrophagesPsychodidaeSequence AlignmentAntigens, SurfaceCytoskeletal ProteinsEukaryotic Initiation Factor-4EEukaryotic Initiation Factor-4G

Identifiers

PMID33760809
PMCPMC8021392
OpenAlexW3137535927

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.